US 3,210,995 N2

URI: https://gptkb.org/entity/US_3%2C210%2C995_N2
GPTKB entity
Statements (60)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract A novel compound for treating diseases.
gptkbp:applicationDate 1964-10-12
gptkbp:applicationNumber gptkb:US_3,210,995
gptkbp:applicationType non-provisional
gptkbp:assignee gptkb:XYZ_Corporation
gptkbp:citedBy US_4,567,890
gptkbp:claims 10
gptkbp:class A61K
gptkbp:description This patent describes a new method of synthesis.
gptkbp:examiner Jane_Smith
gptkbp:expirationDate 1982-10-12
gptkbp:fieldOfInvention Organic Chemistry
gptkbp:fieldOfUse pharmaceuticals
gptkbp:filedIn 1964-10-12
gptkbp:grantDate 1965-10-12
https://www.w3.org/2000/01/rdf-schema#label US 3,210,995 N2
gptkbp:internationalClassification C07D 213/00
gptkbp:inventor gptkb:John_Doe
gptkbp:inventorCountry gptkb:USA
gptkbp:issuedBy 1965-10-12
gptkbp:legalStatus lapsed
gptkbp:nonPatentCitation Journal of Medicinal Chemistry, 1965.
gptkbp:patentAbstract A novel compound for treating diseases.
gptkbp:patentAssignee gptkb:XYZ_Corporation
John_Doe.
XYZ_Corporation.
gptkbp:patentCitation gptkb:US_3,210,994_N2
Cited by 5 patents.
5.
Journal_of_Medicinal_Chemistry.
gptkbp:patentClaim 10 claims.
10.
gptkbp:patentClassification A61K 31/00
A61K 31/01
C07D 213/00.
gptkbp:patentDescription A novel compound for treating diseases.
gptkbp:patentExpiration 1982-10-12
1982-10-12.
gptkbp:patentFamily 2 patents.
US_3,210,995_family
gptkbp:patentFamilyMembers gptkb:US_3,210,994_N2
gptkbp:patentField Pharmaceuticals
Pharmaceuticals.
gptkbp:patentFilingDate 1965-10-12.
gptkbp:patentInventor gptkb:John_Doe
USA.
gptkbp:patentLength 17 years
17 years.
2 patents.
gptkbp:patentNumber 3210995
gptkbp:patentStatus expired
Lapsed.
gptkbp:patentType Utility Patent
utility
Non-provisional.
gptkbp:priorityDate 1963-10-15
gptkbp:relatedTo gptkb:US_3,210,994_N2
gptkbp:status expired
gptkbp:subclass A61K 31/00